A single arm clinical study to evaluate the efficacy of kalyanaka guda in the management of irritable bowel syndrome with special reference to vatika grahani - nil

ational Institute of Ayurveda, Deemed to be University, Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

研究概览

暂无简介。

•1.Patients between the age group of 18 to 60 years.
•2.Patients irrespective of sex and socio- economic status.
•3.Patients having signs and symptoms (abdominal pain and altered bowel habits) of
•Irritable Bowel Syndrome and Vatika Grahani like parshvavankshanruk, chiraat dukham drav shushkam tanu..punah punah srujeta varchah..

•1. Mixed infection with parasites like round worms, hook worms etc.
•2. Patients with bleeding per rectum.
•3. Patients with evidence of malignancy.
•4. Patients having concomitant illness like hypertension, diabetes mellitus type II,
•Amoebic dysentery, Ulcerative colitis, Malabsorption syndrome,
•Inflammatory Bowel Diseases & Intestinal tuberculosis, Lactase deficiency
•5. Patients suffering from major systemic illness like cancer, crohn’s disease, renal
•failure etc.
•6. Patients who are taking corticosteroids, antidepressants, anticholinergic, or
•any other drugs that may have an influence on the outcome of study.
•7. Alcoholics and drug abusers.
•8. Pregnant and lactating women.
•9. Patients who have completed participation in any other clinical trial during the
•past six months.

发起方

ational Institute of Ayurveda, Deemed to be University, Jaipur